Loading
1 standard-of-care settings across 1 lines and 1 biomarker subgroup. Rows come from the cancer page's standard of care; the grid places each on its line and subgroup.
| Line | All comers |
|---|---|
| Early / localised | 1 |
| Subgroup | Setting | Approach | Products and trials | Guideline | Evidence |
|---|---|---|---|---|---|
| All comers | Localised disease | Resection with adjuvant chemotherapy decided by stage as for colorectal adenocarcinoma of no special type; the deceptive biopsy appearance means the diagnosis is often made only on the resection specimen. | NICE NG151: colorectal cancer (published January 2020, last updated December 2021, last reviewed April 2026) | 82 |
Lines and subgroups are parsed from the setting text of each standard-of-care row and can misclassify an unusual phrasing; the row’s own setting is always shown. Guideline chips reflect the NCCN category and ESMO-MCBS grade recorded on the cancer page, checked on its stated date. Not medical advice.